Titre :
  • Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17.
Auteur : Goss, Paul ; Ingle, James N ; Martino, S ; Robert, Nicholas J ; Muss, Hyman B ; Piccart-Gebhart, Martine ; Castiglione, Monica ; Tu, Dongsheng ; Shepherd, L ; Pritchard, Kathleen ; Livingston, Robert ; Davidson, Nancy E ; Norton, Larry ; Perez, Edith A ; Abrams, Jeffrey S ; Cameron, David A ; Palmer, Michael J ; Pater, Joseph L
Informations sur la publication : Journal of the National Cancer Institute, 97, 17, (page 1262-1271)
Statut de publication : Publié, 2005-09
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés MeSH : Aged
Antineoplastic Agents, Phytogenic -- therapeutic use
Antineoplastic Combined Chemotherapy Protocols -- adverse effects
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Aromatase Inhibitors -- therapeutic use
Breast Neoplasms -- chemistry
Breast Neoplasms -- drug therapy
Breast Neoplasms -- pathology
Chemotherapy, Adjuvant
Disease-Free Survival
Female
Humans
Incidence
Lymphatic Metastasis
Middle Aged
Nitriles -- adverse effects
Nitriles -- therapeutic use
Postmenopause
Receptors, Estrogen -- analysis
Receptors, Progesterone -- analysis
Survival Analysis
Tamoxifen -- adverse effects
Tamoxifen -- therapeutic use
Treatment Outcome
Triazoles -- adverse effects
Triazoles -- therapeutic use
Note : Clinical Trial
Journal Article
Randomized Controlled Trial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.
Langue :
  • Anglais
Identificateurs : urn:issn:0027-8874 
info:doi/10.1093/jnci/dji250
info:pii/97/17/1262
info:pmid/16145047